Table 1.
Key characteristics of individual patient data included in the cost‐effectiveness model (based on randomized controlled trial data)
| Characteristic | Patient population (LVEF) | ||
|---|---|---|---|
| Alla | 25–34% | 35–45% | |
| Total number of patients (n) | 415 | 320 | 95 |
| Baseline NYHA class | NYHA III | ||
| Starting age, mean (years) | 60.7 | 60.9 | 60.1 |
| Baseline LVEF, mean | 30.8% | 28.9% | 37.1% |
| Baseline MLWHFQ, mean | 55.8 | 55.4 | 57.2 |
| Males | 74.0% | 73.4% | 75.8% |
| Ischaemic | 66.7% | 68.8% | 60.0% |
| Diabetic | 46.3% | 45.3% | 49.5% |
LVEF, left ventricular ejection fraction; MLWHFQ, Minnesota Living with Heart Failure Questionnaire NYHA, New York Health association.
a
Refers to all patients included in the model; that is, LVEF of 25–45%.